4.7 Article

Efficient sonodynamic ablation of deep-seated tumors via cancer-cell-membrane camouflaged biocompatible nanosonosensitizers

Journal

JOURNAL OF COLLOID AND INTERFACE SCIENCE
Volume 644, Issue -, Pages 388-396

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jcis.2023.04.088

Keywords

Cell membrane; Camouflage; Sonosensitizer; Homotypic targeting; Sonodynamic therapy

Ask authors/readers for more resources

Ultrasound-triggered therapies for cancer treatments can be enhanced through the camouflage of cancer cell membrane (CCM)-coated sonosensitizers. In this study, hemoporfin was encapsulated in poly(lactic acid) polymers (H@PLA) and extruded with CCM from Colon Tumor 26 (CT26) cells to form H@PLA@CCM. Under ultrasound excitation, the H@PLA@CCM nanoparticles showed efficient sonodynamic therapy (SDT) by converting O2 into cytotoxic 1O2. The combination of H@PLA@CCM and ultrasound irradiation induced significant apoptosis and necrosis of tumor cells, achieving a high inhibition rate of tumors.
Ultrasound (US)-triggered therapies are promising in cancer treatments, and their effectiveness can be enhanced through the proper camouflage of sonosensitizers. Herein, we have constructed cancer cell membrane (CCM)camouflaged sonosensitizers for homotypic tumor-targeted sonodynamic therapy (SDT). The camouflaged sonosensitizers have been prepared by encapsulating hemoporfin molecules in poly(lactic acid) polymers (H@PLA) and extruding with CCM from Colon Tumor 26 (CT26) cells, forming the H@PLA@CCM. Under excitation with US, the hemoporfin encapsulated in H@PLA@CCM can convert O2 into cytotoxic 1O2, which exerts an efficient sonodynamic effect. The H@PLA@CCM nanoparticles show enhanced cellular internalization to CT26 cells compared to H@PLA, and they also can be more efficiently engulfed by CT26 cells than by mouse breast cancer cells, due to the homologous targeting ability of CT26 CCM. After the intravenous injection, the blood circulation half-life of H@PLA@CCM is determined to be 3.23 h which is 4.3-time that of H@PLA. With high biosafety, homogeneous targeting ability, and sonodynamic effect, the combination of H@PLA@CCM and US irradiation has induced significant apoptosis and necrosis of tumor cells through the efficient SDT, achieving the strongest inhibition rate of tumors among other groups. This study provides insights into designing efficient and targeted cancer therapies using CCM-camouflaged sonosensitizers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available